TGFB1 and cholangiocarcinoma: In another report, treatment of Huh28 and RBE CCA cell lines with the 3-hydroxy-3-methylglutaryl-coenzyme-CoA (HMG-CoA) reductase inhibitor, lovastatin, resulted in reduced TGFβ1 expression as well as reduced tumor cell proliferation and migration [79].